SEATTLE, MILAN, July 30 — AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced a new partnership with Altheia Science, a gene therapy company pioneering cell and gene therapy strategies to treat autoimmune diseases and cancer.
Through this partnership, Altheia Science will advance its development of autoimmunity
